Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Heavier individuals may require higher doses to achieve equivalent NNMT inhibition due to larger adipose tissue mass and potentially higher baseline NNMT activity
"FDA Approves New Medication for Chronic Weight Management." Accessed on November 7, 2023 at Lilly's Zepbound Official Website
Nerve conduction studies or electromyography are generally reserved for atypical presentations (such as marked asymmetry, predominant motor involvement, or rapid progression), diagnostic uncertainty, or when other causes are suspected
Wait between sprays
Headaches Headaches are another less common side effect
US$ 25.01
US$ 26.00
US$ 20.08
US$ 24.30
US$ 21.13
US$ 29.19
US$ 20.93
US$ 24.13
US$ 22.40
